Inventor
Jeanmarie Guenot
Inventor
San Francisco, CA, US
Overview
Patents· 12 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations38%
C07KPeptides38%
A61KPreparations for medical, dental or toiletry purposes25%
PatentTitleYear
10,954,311Trispecific binding proteins and methods of use202110,849,973Prostate specific membrane antigen binding protein202010,844,134PSMA targeting trispecific proteins and methods of use202010,738,118Methods of using bispecific CD33 and CD3 binding proteins202010,626,190Bispecific CD33 and CD3 binding proteins202010,544,221Single chain variable fragment CD3 binding proteins202010,100,106Single domain serum albumin binding protein201810,066,016Single chain variable fragment CD3 binding proteins20189,920,115'Single domain serum albumin binding protein'20189,803,029'Bispecific CD33 and CD3 binding proteins'20179,708,412'Trispecific binding proteins and methods of use'20179,212,225'Bispecific CD33 and CD3 binding proteins'2015Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2015–2020Patents assigned to AMPHIVENA THERAPEUTICS INC (4)· patent assignee history
2015–2021Based in San Francisco, CA, US· patent location history
2017–2021Patents assigned to HARPOON THERAPEUTICS INC (8)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HARPOON THERAPEUTICS INC | 8 | 2017–2021 |
| AMPHIVENA THERAPEUTICS INC | 4 | 2015–2020 |
Locations
| Location | Patents | Span |
|---|---|---|
| San Francisco, California, US | 12 | 2015–2021 |